Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 3,059 | 5,981 | 4,064 | 4,404 | 4,840 |
| Operating Income | -3,059 | -5,981 | -4,064 | -4,404 | -4,840 |
| Other Income | 151 | 56 | -254 | -37 | 7 |
| Pre-tax Income | -2,908 | -5,925 | -4,318 | -4,441 | -4,834 |
| Net Income Continuous | -2,908 | -5,831 | -4,318 | -4,441 | -4,834 |
| Net Income | $-2,908 | $-5,831 | $-4,318 | $-4,441 | $-4,834 |
| EPS Basic Total Ops | -81.25 | -168.75 | -137.50 | -156.25 | -187.50 |
| EPS Basic Continuous Ops | -78.50 | -169.43 | -135.96 | -157.80 | -189.86 |
| EPS Diluted Total Ops | -81.25 | -168.75 | -137.50 | -156.25 | -187.50 |
| EPS Diluted Continuous Ops | -78.50 | -169.43 | -135.96 | -157.80 | -189.86 |
| EBITDA(a) | $-3,044 | $-5,965 | $-4,051 | $-4,390 | $-4,828 |